Document is current
Any future updates will be listed below
-
Authors
Rovers, Koen P.
Wassenaar, Emma C. E.
Lurvink, Robin J.
Creemers, Geert-Jan M.
Burger, Jacobus W. A.
Los, Maartje
Huysentruyt, Clément J. R.
van Lijnschoten, Gesina
Nederend, Joost
Lahaye, Max J.
Deenen, Maarten J.
Wiezer, Marinus J.
Nienhuijs, Simon W.
Boerma, Djamila
de Hingh, Ignace H. J. T.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03246321 at ClinicalTrials.govDocuments that mention this clinical trial
Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC) (Pre-results)
https://doi.org/10.1136/bmjopen-2019-030408
Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC)
https://doi.org/10.1245/s10434-020-09558-4
-
Funding
Funding for this research was provided by:
Sint Antonius Research Foundation (17-4)
Catharina Research Foundation (2017-5)
- License Information
-
More Information
Article History
Received: 19 October 2020
Accepted: 23 December 2020
First Online: 5 February 2021
Disclosures
: Prof. Dr. Ignace H.J.T. de Hingh received research grants (paid to the institute) from QP&S/RanD and F. Hoffman-La Roche for research unrelated to the submitted work. Koen P. Rovers, Emma C.E. Wassenaar, Robin J. Lurvink, Geert-Jan M. Creemers, Jacobus W.A. Burger, Maartje Los, Clément J.R. Huysentruyt, Gesina van Lijnschoten, Joost Nederend, Max J. Lahaye, Maarten J. Deenen, Marinus J. Wiezer, Simon W. Nienhuijs, and Djamila Boerma declare no conflicts of interest.
